A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus
- PMID: 11829519
- DOI: 10.1006/mthe.2002.0525
A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus
Abstract
The immune response after ocular exposure to foreign antigens varies substantially from that of a typical systemic response. Anterior chamber associated immune deviation (ACAID) has been well documented. The immune response of the subretinal space has not been studied in as much detail. Here, we characterized the immune response of the subretinal space when it encounters the antigens AdV-GFP and AAV-GFP (recombinant adenovirus or adeno-associated virus, respectively), each delivering the reporter gene encoding green fluorescent protein (GFP). Results indicate that the subretinal space possesses an immune-deviant property similar to ACAID. AdV-elicited immune responses following subretinal injections are significantly reduced compared with systemic responses elicited by intradermal injections of the same virus. Furthermore, subretinal AdV administration results in transduction of retinal pigment epithelial cells (RPE), which are the potential antigen presenting cells of the retina. This subsequently generates a population of immunosuppressive Th2-type, cytokine-secreting, splenic T cells. This response may be advantageous to the development of ocular gene therapy.
Similar articles
-
Additional transduction events after subretinal readministration of recombinant adeno-associated virus.Hum Gene Ther. 2000 Feb 10;11(3):449-57. doi: 10.1089/10430340050015914. Hum Gene Ther. 2000. PMID: 10697119
-
Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.Curr Gene Ther. 2017;17(3):235-247. doi: 10.2174/1566523217666171003170348. Curr Gene Ther. 2017. PMID: 28982327
-
Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction.Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2857-63. Invest Ophthalmol Vis Sci. 1997. PMID: 9418740
-
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.Gene Ther. 2003 Jun;10(11):955-63. doi: 10.1038/sj.gt.3302037. Gene Ther. 2003. PMID: 12756416 Review.
-
Immunosuppressive properties of the pigmented epithelial cells and the subretinal space.Chem Immunol Allergy. 2007;92:86-93. doi: 10.1159/000099259. Chem Immunol Allergy. 2007. PMID: 17264485 Review.
Cited by
-
Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the Hedgehog.Front Immunol. 2021 Oct 29;12:753467. doi: 10.3389/fimmu.2021.753467. eCollection 2021. Front Immunol. 2021. PMID: 34777364 Free PMC article. Review.
-
Has retinal gene therapy come of age? From bench to bedside and back to bench.Hum Mol Genet. 2019 Oct 1;28(R1):R108-R118. doi: 10.1093/hmg/ddz130. Hum Mol Genet. 2019. PMID: 31238338 Free PMC article. Review.
-
Safety of Same-Eye Subretinal Sequential Readministration of AAV2-hRPE65v2 in Non-human Primates.Mol Ther Methods Clin Dev. 2019 Sep 3;15:133-148. doi: 10.1016/j.omtm.2019.08.011. eCollection 2019 Dec 13. Mol Ther Methods Clin Dev. 2019. PMID: 31660416 Free PMC article.
-
And Then There Was Light: Perspectives of Optogenetics for Deep Brain Stimulation and Neuromodulation.Front Neurosci. 2017 Dec 12;11:663. doi: 10.3389/fnins.2017.00663. eCollection 2017. Front Neurosci. 2017. PMID: 29311765 Free PMC article. Review.
-
Differential targeting of feline photoreceptors by recombinant adeno-associated viral vectors: implications for preclinical gene therapy trials.Gene Ther. 2014 Oct;21(10):913-20. doi: 10.1038/gt.2014.65. Epub 2014 Jul 24. Gene Ther. 2014. PMID: 25056608 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources